Evidence map›Paper›PMID 41378222›Full record

ArticleFrontiers in pharmacology2025

Trend analysis and future projections of global burden of opioid use disorder (OUD) from 1990 to 2030.

Wenshuo Jiang, Zhigang Zhao, Bin Zhu

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wenshuo JiangDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Zhigang ZhaoDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Bin ZhuDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Opioid Use Disorder (OUD) is a chronic medical crisis which represents significant public health challenge on global scale. We aim to provide long-term trends and future projections of OUD for effective intervention. Methods: This study utilized data from the Global Burden of Disease (GBD) study 2021 for analysis. OUD burden was assessed using absolute numbers and age-standardized rates of incidence (ASIR), prevalence (ASPR), disability-adjusted life years (ASDR), and mortality (ASMR) per 100,000 population, with 95% uncertainty intervals (UIs). Temporal trends were analyzed using joinpoint regression. Age-period-cohort (APC) models were applied to assess the independent effects of age, time period, and birth cohort on OUD burden. Decomposition analysis quantified the relative contributions of population growth, aging, and epidemiological changes to the overall burden variation. Finally, autoregressive integrated moving average (ARIMA) models were used to forecast OUD burden through 2030. Results: In 2021, an estimated 1.94 million new cases and 16.16 million prevalent cases of OUD were recorded globally, resulting in 11.22 million DALYs and nearly 99,556 deaths. The number of incidence, prevalence, DALYs and mortality of OUD all showed substantial increases. The age-standardized rates also increased but the margins were relatively small. The highest levels and fastest growth were observed in high-SDI regions, particularly North America. Males consistently exhibited higher DALY and mortality rates than females. The burden was greatest among individuals aged 15-49 years. Joinpoint analysis revealed fluctuating trends with notable increases after 2010. APC analysis showed peak incidence at ages 20-25 and declining risk in later birth cohorts. Decomposition analysis indicated that population growth and epidemiological changes were the main contributors to the rising burden. ARIMA forecasting predicted continued increases in incidence and DALYs but slight declines in prevalence and mortality by 2030. Conclusion: The global burden of opioid use disorder (OUD) has continued to rise since 1990, mainly driven by population growth and epidemiological changes. Although age-standardized rates have remained stable or increased slightly, regional disparities persist, with the highest burden in high-SDI areas. Forecasts suggest modest increases in incidence and DALYs by 2030, underscoring the need for sustained, adaptive policies and preventive strategies to mitigate the evolving opioid crisis.

Indexed as

DALYsglobal burden of disease studyincidencemortalityopioid use disorder

Identifiers

PMID41378222
PMCPMC12685792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.